Takara Bio Inc. (4974.T)
JPY 1002.0
(-0.2%)
JPY 1002.0
(-0.2%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 43.5 Billion | 78.14 Billion | 67.69 Billion | 46.08 Billion | 34.56 Billion | 35.84 Billion |
| Cost of Revenue | 18.04 Billion | 33.37 Billion | 18.48 Billion | 14.21 Billion | 13.45 Billion | 15.15 Billion |
| Gross Profit | 25.45 Billion | 44.76 Billion | 49.21 Billion | 31.87 Billion | 21.1 Billion | 20.68 Billion |
| Operating Expenses | 23.9 Billion | 24.21 Billion | 20.3 Billion | 17.91 Billion | 14.82 Billion | 15.21 Billion |
| Selling, General and Administrative Expenses | 15.58 Billion | 15.64 Billion | 14.2 Billion | 12.37 Billion | 10.96 Billion | 703 Million |
| Research and Development Expenses | 6.87 Billion | 8.57 Billion | 6.1 Billion | 5.54 Billion | 3.86 Billion | 4.33 Billion |
| Other Expenses | - | 144 Million | 166 Million | 116 Million | 100 Million | 141 Million |
| Cost and Expenses | 40.5 Billion | 57.59 Billion | 38.79 Billion | 32.13 Billion | 28.28 Billion | 30.37 Billion |
| Operating Income | 3 Billion | 20.54 Billion | 28.9 Billion | 13.95 Billion | 6.27 Billion | 5.46 Billion |
| Interest Expense | 23 Million | 24 Million | 23 Million | 24 Million | 7 Million | - |
| Income Tax Expense | 1.34 Billion | 5.17 Billion | 7.62 Billion | 3.97 Billion | 1.6 Billion | 1.14 Billion |
| Earnings before Tax | 2.85 Billion | 21.22 Billion | 27.53 Billion | 13.55 Billion | 5.43 Billion | 4.82 Billion |
| Net Income | 1.48 Billion | 16.01 Billion | 19.84 Billion | 9.54 Billion | 3.81 Billion | 3.65 Billion |
| Earnings Per Share Basic | 12.29 | 132.97 | 164.84 | 79.28 | 31.72 | 30.37 |
| Earnings Per Share Diluted | 12.29 | 132.97 | 164.84 | 79.28 | 31.72 | 30.37 |
| Weighted Average Shares Outstanding | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million |
| Gross Margin | 0.59 | 0.57 | 0.73 | 0.69 | 0.61 | 0.58 |
| EBIT Margin | 0.18 | 0.33 | 0.48 | 0.39 | 0.29 | 0.27 |
| Profit Margin | 0.03 | 0.20 | 0.29 | 0.21 | 0.11 | 0.10 |
| EBITDA | 8.02 Billion | 25.27 Billion | 33.05 Billion | 17.73 Billion | 9.8 Billion | 8.84 Billion |
| Earnings Before Tax Margin | 0.07 | 0.26 | 0.43 | 0.30 | 0.18 | 0.15 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 8.49 Billion | 13.77 Billion | 43.5 Billion | 10.61 Billion | 9.94 Billion | 9.17 Billion |
| Cost of Revenue | 4.13 Billion | 4.9 Billion | 18.04 Billion | 5.92 Billion | 3.08 Billion | 2.68 Billion |
| Gross Profit | 4.35 Billion | 8.86 Billion | 25.45 Billion | 4.69 Billion | 6.85 Billion | 6.49 Billion |
| Operating Expenses | 5.98 Billion | 6.2 Billion | 22.45 Billion | 5.77 Billion | 5.86 Billion | 6.06 Billion |
| Selling, General and Administrative Expenses | 4.03 Billion | 3.99 Billion | - | 3.93 Billion | 3.71 Billion | 3.61 Billion |
| Research and Development Expenses | 1.7 Billion | 2.2 Billion | - | 1.87 Billion | 2 Billion | 2.24 Billion |
| Other Expenses | 245 Million | 73 Million | 143 Million | 27 Million | 21 Million | 22 Million |
| Cost and Expenses | 10.12 Billion | 11.1 Billion | 40.5 Billion | 11.69 Billion | 8.95 Billion | 8.75 Billion |
| Operating Income | -1.63 Billion | 2.66 Billion | 3 Billion | -1.07 Billion | 987 Million | 423 Million |
| Interest Expense | 7 Million | 5 Million | 23 Million | 6 Million | 5 Million | 7 Million |
| Income Tax Expense | 476 Million | 1.02 Billion | 1.34 Billion | -166 Million | 317 Million | 172 Million |
| Earnings before Tax | -1.5 Billion | 2.35 Billion | 2.85 Billion | -1.08 Billion | 1.08 Billion | 505 Million |
| Net Income | -1.04 Billion | 1.32 Billion | 1.48 Billion | -930 Million | 765 Million | 319 Million |
| Earnings Per Share Basic | -8.69 | 11.01 | - | -7.72 | 6.35 | 2.65 |
| Earnings Per Share Diluted | -8.69 | 11.01 | - | -7.72 | 6.35 | 2.65 |
| Weighted Average Shares Outstanding | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million | 120.41 Million |
| Gross Margin | 0.51 | 0.64 | 0.59 | 0.44 | 0.69 | 0.71 |
| EBIT Margin | -0.06 | 0.28 | - | 0.03 | 0.24 | 0.19 |
| Profit Margin | -0.12 | 0.10 | 0.03 | -0.09 | 0.08 | 0.03 |
| EBITDA | -508 Million | 3.88 Billion | - | 307 Million | 2.36 Billion | 1.73 Billion |
| Earnings Before Tax Margin | -0.19 | 0.19 | 0.07 | -0.10 | 0.10 | 0.05 |
GBOOF
CHMK
1133
3187
0IJR
0L9G